首页> 外国专利> Combination of (a) n-5-4-(4-methyl-piperazino-methyl)-benzoylamido-2methylphenyl-4-(3-pyridyl)-2-pyrimidine-amine and (b) at least one hypusination inhibitor and the use thereof

Combination of (a) n-5-4-(4-methyl-piperazino-methyl)-benzoylamido-2methylphenyl-4-(3-pyridyl)-2-pyrimidine-amine and (b) at least one hypusination inhibitor and the use thereof

机译:(a)n- [5- [4-(4-甲基-哌嗪子甲基)-苯甲酰氨基] -2甲基苯基] -4-(3-吡啶基)-2-嘧啶-胺的组合和(b)至少一种羟甲基化抑制剂及其用途

摘要

The invention relates to a method of treating a warm-blooded animal, especially a human, having a proliferative disease comprising administering to the animal a combination which comprises (a) N-{5-[4-(4-methyl-(piperazine-1-yl)-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and (b) at least one hypusination inhibitor, to a combination comprising (a) and (b) as defined above and optionally at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use, in particular for the delay of progression or treatment of a proliferative disease and finally to the use of at least one hypusination inhibitor for the preparation of a medicament for the delay of progression or treatment of leukemia, particularly Imatinib-resistant leukemia.
机译:本发明涉及一种治疗患有增生性疾病的温血动物,特别是人的方法,该方法包括给该动物施用一种包含(a)N- {5- [4-(4-甲基-(哌嗪- 1-基)-甲基)-苯甲酰氨基] -2-甲基苯基} -4-(3-吡啶基)-2-嘧啶-胺和(b)至少一种催眠抑制剂,形成包含(a)和(b)的组合如上文所定义的,以及任选地至少一种药学上可接受的载体,其用于同时,分开或相继使用,特别是用于延缓增生性疾病的进展或治疗,以及最终用于至少一种羟化酶抑制剂用于制备用于延缓白血病的发展或治疗,特别是对伊马替尼耐药的白血病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号